Champions Oncology (NASDAQ:CSBR) is scheduled to be releasing its earnings data after the market closes on Monday, July 15th. Analysts expect Champions Oncology to post earnings of $0.03 per share for the quarter.
CSBR opened at $7.96 on Friday. Champions Oncology has a 1-year low of $5.80 and a 1-year high of $17.90. The firm has a fifty day simple moving average of $8.71. The company has a market cap of $92.42 million, a PE ratio of -56.86 and a beta of 1.07.
Separately, Zacks Investment Research cut Hersha Hospitality Trust from a “buy” rating to a “hold” rating in a research note on Thursday, May 2nd.
Champions Oncology, Inc develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice.
Recommended Story: Net Income
Receive News & Ratings for Champions Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Champions Oncology and related companies with MarketBeat.com's FREE daily email newsletter.